Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8106006
Modified defensins and their use
granted -
US 8106027
Development of a preventive vaccine for filovirus infection in primates
granted -
US 8101380
Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs
granted -
US 8101739
Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
granted -
US 8101172
Solenopsis invicta virus
granted -
US 8093343
Nitric oxide-releasing diazeniumdiolated compounds
granted -
US 8092809
Pseudomonas exotoxin A-like chimeric immunogens
granted -
US 8088729
Anti-viral griffithsin compounds, compositions and methods of use
granted -
US 8088379
Modified T cell receptors and related materials and methods
granted -
US 8088787
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted -
US 8084415
Uteroglobin in the treatment of IGA mediated nephropathy
granted -
US 8084594
H2N3 influenza A viruses and methods of use
granted -
US 8084250
Defensin-antigen fusion proteins
granted -
US 8084199
Method of diagnosing poor survival prognosis colon cancer using microRNA-21
granted -
US 8080554
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 8076100
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
granted -
US 8075900
Melanoma associated peptide analogues and vaccines against melanoma
granted -
US 8075903
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
granted -
US 8075921
Rapamycin-resistant T cells and therapeutic uses thereof
granted -
US 8071323
Human monoclonal antibodies that bind human insulin like growth factors and their use
granted -
US 8071113
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted -
US 8071084
Vaccine for protection against Shigella sonnei disease
granted -
US 8071746
Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3
granted -
US 8067530
Scytovirin domain 1 related polypeptides
granted